# Phase I Clinical Trial of CT0180 Cells in the Treatment of Hepatocellular Carcinoma

> **NCT04756648** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Zhejiang University** · enrollment: 21 (estimated)

## Conditions studied

- Advanced Hepatocellular Carcinoma

## Interventions

- **DRUG:** CT0180 Cells

## Key facts

- **NCT ID:** NCT04756648
- **Lead sponsor:** Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-03-10
- **Primary completion:** 2023-03-31
- **Final completion:** 2026-06-01
- **Target enrollment:** 21 (ESTIMATED)
- **Last updated:** 2025-09-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04756648

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04756648, "Phase I Clinical Trial of CT0180 Cells in the Treatment of Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04756648. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*